Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly raises 2012 net profit forecast
Reuters
Thursday, August 9, 2012 - 10:59am
tags:
Lilly, guidance
AstraZeneca buys equal say over Amylin drugs
Reuters
Thursday, August 9, 2012 - 10:56am
tags:
Amylin, AstraZeneca, diabetes, Bristol-Myers Squibb
Diabetes May Be Reversed By Long-Used Vaccine For TB
Bloomberg
Thursday, August 9, 2012 - 10:55am
tags:
vaccines, tuberculosis, type 1 diabetes, bacillus Calmette-Guérin
Bristol-Myers completes acquisition of Amylin
Yahoo/Fly on the Wall
Thursday, August 9, 2012 - 10:43am
tags:
M&A, Amylin, Bristol-Myers Squibb
Savient jumps 14% after earnings report
Marketwatch
Wednesday, August 8, 2012 - 12:06pm
tags:
earnings, Savient
Spectrum drops 14% after earnings report
Marketwatch
Wednesday, August 8, 2012 - 12:04pm
tags:
Spectrum Pharmaceuticals, earnings
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wednesday, August 8, 2012 - 12:04pm
tags:
Pluristem, Amgen, AstraZeneca, Celgene, Dendreon, Eli Lilly, Medivation, Merck, Onyx, Pfizer, bone marrow disorder
Pfizer: In Need of a Blockbuster Drug Now
Motley Fool
Wednesday, August 8, 2012 - 12:02pm
tags:
Pfizer
Charles River Labs 2Q income falls 6 percent
Yahoo/AP
Wednesday, August 8, 2012 - 11:54am
tags:
earnings, Charles River Laboratories
Clovis Oncology Announces Second Quarter 2012 Operating Results
Yahoo
Wednesday, August 8, 2012 - 11:54am
tags:
earnings, Clovis Oncology
Warner Chilcott Ends Sale Effort, Announces Dividend
Bloomberg
Wednesday, August 8, 2012 - 11:53am
tags:
dividends, Warner Chilcott
Antitrust Suit Over Sanofi Vaccine Can Proceed
Pharmalot
Wednesday, August 8, 2012 - 11:52am
tags:
Sanofi, vaccines, antitrust, Novartis, Menactra
Vanda Pharmaceuticals: More Than Enough Cash On Hand To Buy Themselves
Seeking Alpha
Wednesday, August 8, 2012 - 11:33am
tags:
Vanda, Pfizer, Eli Lilly, JNJ, Bristol-Myers Squibb, Acadia
Merck says key data on Zetia cholesterol drug due in 2014
Reuters
Wednesday, August 8, 2012 - 11:14am
tags:
Merck, Zetia
Lilly Last Hope For Alzheimer’s As Pfizer, J&J Bow Out
Bloomberg
Wednesday, August 8, 2012 - 11:01am
tags:
Pfizer, Eli Lilly, JNJ, bapineuzumab, Alzheimer's disease, solanezumab, Baxter International, Gammagard
Lundbeck In Talks With Possible Alzheimer’s Drug Partners
Bloomberg
Wednesday, August 8, 2012 - 10:45am
tags:
Alzheimer's disease, Lundbeck, AE58054
Vivus rises ahead of 2nd-quarter earnings report
Yahoo/AP
Tuesday, August 7, 2012 - 5:58pm
tags:
Vivus, earnings
Achillion announces SVR4 of 85%-100% from trial evaluating sovaprevir
Yahoo/Fly on the Wall
Tuesday, August 7, 2012 - 5:56pm
tags:
Achillion, sovaprevir, hepatitis C
Chelsea Therapeutics Earnings: Loss Narrowed
Wall St. Cheat Sheet
Tuesday, August 7, 2012 - 5:55pm
tags:
earnings, Chelsea Therapeutics
Decision Date for Medivation Drug
Yahoo/Zacks
Tuesday, August 7, 2012 - 5:53pm
tags:
Medivation, Astellas, Enzalutamide, prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.